SPL 1.02% 9.7¢ starpharma holdings limited

Vivagel marketing, page-3

  1. 587 Posts.
    lightbulb Created with Sketch. 79
    My expectations for vivagel continue to dwindle.

    I hoped sales would help fund Dep trials but this seems increasingly unlikely. Disappointing, but if the Dep trials are successful all will be ok.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.